Ira Duarte
CFO
CFO
Board Member
Chief Accounting Officer
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Heron Therapeutics, Inc. /De/ (HRTX) | EVP, Chief Financial Officer | $559,803 | $1,630,678 |
| 2024 | Heron Therapeutics, Inc. /De/ (HRTX) | EVP, Chief Financial Officer | $592,250 | $1,536,130 |
| 2023 | Heron Therapeutics, Inc. /De/ (HRTX) | EVP, Chief Financial Officer | $271,154 | $1,534,873 |
| 2022 | Heron Therapeutics, Inc. /De/ (HRTX) | EVP, Chief Financial Officer | — | — |
Executive changes
Earnings-call appearances
-
Heron Therapeutics, Inc. /De/ Q1 FY2026 Earnings Call2026-05-11
Heron Therapeutics, Inc. /De/ (HRTX)
-
Heron Therapeutics, Inc. /De/ Q4 FY2025 Earnings Call2026-02-26
Heron Therapeutics, Inc. /De/ (HRTX)
-
Heron Therapeutics, Inc. /De/ Q3 FY2025 Earnings Call2025-11-04
Heron Therapeutics, Inc. /De/ (HRTX)
-
Heron Therapeutics, Inc. /De/ Q2 FY2025 Earnings Call2025-08-08
Heron Therapeutics, Inc. /De/ (HRTX)
-
Heron Therapeutics, Inc. /De/ Q1 FY2025 Earnings Call2025-05-06
Heron Therapeutics, Inc. /De/ (HRTX)
-
Heron Therapeutics, Inc. /De/ Q4 FY2024 Earnings Call2025-02-27
Heron Therapeutics, Inc. /De/ (HRTX)
-
Heron Therapeutics, Inc. /De/ Q3 FY2024 Earnings Call2024-11-12
Heron Therapeutics, Inc. /De/ (HRTX)
-
Heron Therapeutics, Inc. /De/ Q2 FY2024 Earnings Call2024-08-06
Heron Therapeutics, Inc. /De/ (HRTX)
-
Heron Therapeutics, Inc. /De/ Q1 FY2024 Earnings Call2024-05-07
Heron Therapeutics, Inc. /De/ (HRTX)
-
Heron Therapeutics, Inc. /De/ Q4 FY2023 Earnings Call2024-03-12
Heron Therapeutics, Inc. /De/ (HRTX)
-
Heron Therapeutics, Inc. /De/ Q3 FY2023 Earnings Call2023-11-14
Heron Therapeutics, Inc. /De/ (HRTX)
-
Heron Therapeutics, Inc. /De/ Q2 FY2023 Earnings Call2023-08-14
Heron Therapeutics, Inc. /De/ (HRTX)